Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes.

Cheng Q, Yang W, Raimondi SC, Pui CH, Relling MV, Evans WE.

Nat Genet. 2005 Aug;37(8):878-82. Epub 2005 Jul 24.

PMID:
16041371
2.

Epigenetic regulation of human gamma-glutamyl hydrolase activity in acute lymphoblastic leukemia cells.

Cheng Q, Cheng C, Crews KR, Ribeiro RC, Pui CH, Relling MV, Evans WE.

Am J Hum Genet. 2006 Aug;79(2):264-74. Epub 2006 Jun 6. Erratum in: Am J Hum Genet. 2010 Jul 9;87(1):161.

3.

Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.

Dervieux T, Kremer J, Lein DO, Capps R, Barham R, Meyer G, Smith K, Caldwell J, Furst DE.

Pharmacogenetics. 2004 Nov;14(11):733-9.

PMID:
15564880
4.

Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian-Caucasian population: differences in enzyme activity.

Serpe L, Calvo PL, Muntoni E, D'Antico S, Giaccone M, Avagnina A, Baldi M, Barbera C, Curti F, Pera A, Eandi M, Zara GP, Canaparo R.

Pharmacogenomics. 2009 Nov;10(11):1753-65. doi: 10.2217/pgs.09.103.

PMID:
19891552
5.

Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.

Chrzanowska M, Kuehn M, Januszkiewicz-Lewandowska D, Kurzawski M, Droździk M.

Acta Pol Pharm. 2012 May-Jun;69(3):405-10.

6.

Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis.

Yan L, Zhang S, Eiff B, Szumlanski CL, Powers M, O'Brien JF, Weinshilboum RM.

Clin Pharmacol Ther. 2000 Aug;68(2):210-9.

PMID:
10976552
7.

[Analysis of genetic polymorphisms of thiopurine S-methyltransferase (TPMT) in Mexican pediatric patients with cancer].

Moreno-Guerrero SS, Ramírez-Pacheco A, Dorantes-Acosta EM, Medina-Sanson A.

Rev Invest Clin. 2013 Mar-Apr;65(2):156-64. Spanish.

PMID:
23844534
8.
9.

Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.

Peregud-Pogorzelski J, Tetera-Rudnicka E, Kurzawski M, Brodkiewicz A, Adrianowska N, Mlynarski W, Januszkiewicz D, Drozdzik M.

Pediatr Blood Cancer. 2011 Oct;57(4):578-82. doi: 10.1002/pbc.23013. Epub 2011 Feb 11.

PMID:
21319286
10.

Genetic polymorphism of γ-glutamyl hydrolase in Chinese acute leukemia children and identification of a novel double nonsynonymous mutation.

Chen X, Wen F, Yue L, Li C.

Pediatr Hematol Oncol. 2012 May;29(4):303-12. doi: 10.3109/08880018.2012.657767.

PMID:
22568793
11.

Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients.

Chrzanowska M, Kurzawski M, Droździk M, Mazik M, Oko A, Czekalski S.

Pharmacol Rep. 2006 Nov-Dec;58(6):973-8.

12.

Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.

Wang SM, Sun LL, Zeng WX, Wu WS, Zhang GL.

Cancer Chemother Pharmacol. 2014 Aug;74(2):283-9. doi: 10.1007/s00280-014-2507-8. Epub 2014 Jun 8.

PMID:
24908438
13.

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.

Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, Pui CH, Evans WE.

J Natl Cancer Inst. 1999 Dec 1;91(23):2001-8.

PMID:
10580024
14.

Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.

Schmiegelow K, Forestier E, Kristinsson J, Söderhäll S, Vettenranta K, Weinshilboum R, Wesenberg F; Nordic Society of Paediatric Haematology and Oncology.

Leukemia. 2009 Mar;23(3):557-64. doi: 10.1038/leu.2008.316. Epub 2008 Nov 6.

15.

Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?

Fakhoury M, Andreu-Gallien J, Mahr A, Medard Y, Azougagh S, Vilmer E, Jacqz-Aigrain E.

J Clin Pharm Ther. 2007 Dec;32(6):633-9.

PMID:
18021342
16.

Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.

Dervieux T, Médard Y, Verpillat P, Guigonis V, Duval M, Lescoeur B, Suciu S, Vilmer E, Jacqz-Aigrain E.

Leukemia. 2001 Nov;15(11):1706-12.

PMID:
11681411
17.

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance.

Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE.

Ann Intern Med. 1997 Apr 15;126(8):608-14.

PMID:
9103127
18.

Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia.

Farfan MJ, Salas C, Canales C, Silva F, Villarroel M, Kopp K, Torres JP, Santolaya ME, Morales J.

BMC Cancer. 2014 Apr 28;14:299. doi: 10.1186/1471-2407-14-299.

19.

Thiopurine S-methyltransferase genotype-phenotype concordance: used as a quality assurance tool to help control the phenotype assay.

Ford L, Kampanis P, Berg J.

Ann Clin Biochem. 2009 Mar;46(Pt 2):152-4. doi: 10.1258/acb.2008.008167. Epub 2009 Jan 22.

PMID:
19164342
20.

Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.

Schaeffeler E, Fischer C, Brockmeier D, Wernet D, Moerike K, Eichelbaum M, Zanger UM, Schwab M.

Pharmacogenetics. 2004 Jul;14(7):407-17.

PMID:
15226673

Supplemental Content

Support Center